|
Unomedical hereby submits this initial report as part of its complaint remediation activities conducted under a capa 2356421 and capa 2566479 in accordance with the fda action plan, which incorporates qp-ic-2026-0020 (ic retrospective complaint review) and qp-ic-2026-0024 (ic retrospective mdr review).This submission includes a retrospective reassessment of previously evaluated complaints.Unomedical is providing this supplemental information in accordance with the reporting requirements set forth in 21 cfr part 803.Any fields left blank indicate that the information is unknown, unavailable, or remains unchanged
additional information - this medical device report (mdr)is being submitted to include the below:
h6: investigation results under type of investigation, investigation findings, investigation conclusions
h11: investigation summary
complaint investigation results:
electronic quality management system (eqms) search:
a query was run in the electronic quality management system (eqms) on 28 aug 2026 against lot number 6007169 and similar malfunction codes: insertion site egress - significant wetness pooling, leakage from infusion site (cannula base part/cannula) (specific cause not identified)
the review confirmed that lot 6007169 and the identified failure mode are not associated with any nonconforming reports (ncr) or corrective and preventive action (capa) of the same or similar nature.Similar complaints search:
a query was run in the electronic quality management system (eqms) on 28/aug/2026 against lot number criteria equal 6007169 and similar malfunction codes: insertion site egress - significant wetness / pooling, leakage from infusion site (cannula base part/cannula) (specific cause not identified)
the count of complaint is 1.The complaint number is complaint (b)(4).Batch record / medical device file review:
the lot 6007169 was manufactured according to 4905072 version 114 and manufactured in the machine/line: inset 3, on 18/may/2024 with a total of (b)(4) units.Batch record / medical device file review:
the batch record / medical device file was reviewed.All required in process and final tests were completed and met specified requirements.No deviations were identified, and no maintenance events were recorded that relate to the complaint code.Conclusion:
batch record / medical device file review supports compliance with manufacturing and quality requirements; no issues noted.Visual evidence review:
no photo was provided to support visual confirmation of the reported issue.Conclusion:
unable to perform visual verification; assessment based on available documentation only.Retain samples testing:
retain samples from the relevant lot were previously tested in complaint (b)(4) on 05/mar/2025.Work instruction (wi) guidance for visual testing for complaints area version 3: all 10 samples tested passed visual inspection.Work instruction (wi) guidance for functional testing for complaints area version 2: all 5 samples tested passed air flow testing for the reported malfunction code: insertion site egress - significant wetness / pooling.Work instruction (wi) guidance for functional testing for complaints area version 2: all 5 samples tested passed air leak testing for the reported malfunction code: insertion site egress - significant wetness / pooling.All test results were within specification as documented in the attached database (b)(4).Conclusion:
testing did not confirm the reported issue; no nonconformance identified.Return samples testing:
returned samples from the relevant lot were requested; however, the customer confirmed that the sample is not available for return.Conclusion:
visual and functional testing could not be performed due to lack of sample availability.Assessment will be based on other available evidence.Corrective and preventive action (capa) determination assessment
based on the investigation, no further investigation is required.The record will be closed and monitored through tracking and trending per work instruction (wi) (monthly trips and alerts)
root cause of problem:
the reported failure could not be confirmed following investigation.Therefore, a definitive root cause could not be determined.Corrective action as a result of the investigation:
no corrective actions have been taken as a result of this event.We will continue to monitor for trends as more definitive data is collected through post market surveillance activities under work instruction (wi) eu mdr article 88 trend reporting (trips and alerts) and sop-000741 post market product monitoring procedures.Complaint unconfirmed:
following investigation, the reported failure could not be confirmed for this complaint.Based on the available information, this event is deemed to be a serious injury.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number
reporting site: 8021545
manufacturing site: 3003442380.
|